| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |